Suppr超能文献

2021 年 1 月至 2022 年 4 月,13 个美国州 18 岁及以上接种和未接种疫苗的成年人因 COVID-19 住院的情况。

COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022.

机构信息

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.

Public Health Service Commissioned Corps, Rockville, Maryland.

出版信息

JAMA Intern Med. 2022 Oct 1;182(10):1071-1081. doi: 10.1001/jamainternmed.2022.4299.

Abstract

IMPORTANCE

Understanding risk factors for hospitalization in vaccinated persons and the association of COVID-19 vaccines with hospitalization rates is critical for public health efforts to control COVID-19.

OBJECTIVE

To determine characteristics of COVID-19-associated hospitalizations among vaccinated persons and comparative hospitalization rates in unvaccinated and vaccinated persons.

DESIGN, SETTING, AND PARTICIPANTS: From January 1, 2021, to April 30, 2022, patients 18 years or older with laboratory-confirmed SARS-CoV-2 infection were identified from more than 250 hospitals in the population-based COVID-19-Associated Hospitalization Surveillance Network. State immunization information system data were linked to cases, and the vaccination coverage data of the defined catchment population were used to compare hospitalization rates in unvaccinated and vaccinated individuals. Vaccinated and unvaccinated patient characteristics were compared in a representative sample with detailed medical record review; unweighted case counts and weighted percentages were calculated.

EXPOSURES

Laboratory-confirmed COVID-19-associated hospitalization, defined as a positive SARS-CoV-2 test result within 14 days before or during hospitalization.

MAIN OUTCOMES AND MEASURES

COVID-19-associated hospitalization rates among vaccinated vs unvaccinated persons and factors associated with COVID-19-associated hospitalization in vaccinated persons were assessed.

RESULTS

Using representative data from 192 509 hospitalizations (see Table 1 for demographic information), monthly COVID-19-associated hospitalization rates ranged from 3.5 times to 17.7 times higher in unvaccinated persons than vaccinated persons regardless of booster dose status. From January to April 2022, when the Omicron variant was predominant, hospitalization rates were 10.5 times higher in unvaccinated persons and 2.5 times higher in vaccinated persons with no booster dose, respectively, compared with those who had received a booster dose. Among sampled cases, vaccinated hospitalized patients with COVID-19 were older than those who were unvaccinated (median [IQR] age, 70 [58-80] years vs 58 [46-70] years, respectively; P < .001) and more likely to have 3 or more underlying medical conditions (1926 [77.8%] vs 4124 [51.6%], respectively; P < .001).

CONCLUSIONS AND RELEVANCE

In this cross-sectional study of US adults hospitalized with COVID-19, unvaccinated adults were more likely to be hospitalized compared with vaccinated adults; hospitalization rates were lowest in those who had received a booster dose. Hospitalized vaccinated persons were older and more likely to have 3 or more underlying medical conditions and be long-term care facility residents compared with hospitalized unvaccinated persons. The study results suggest that clinicians and public health practitioners should continue to promote vaccination with all recommended doses for eligible persons.

摘要

重要性

了解接种者住院的风险因素以及 COVID-19 疫苗与住院率的关联,对于控制 COVID-19 的公共卫生工作至关重要。

目的

确定接种者中与 COVID-19 相关的住院的特征,以及未接种者和接种者的住院率比较。

设计、地点和参与者:从 2021 年 1 月 1 日至 2022 年 4 月 30 日,从 250 多家医院的基于人群的 COVID-19 相关住院监测网络中确定了 18 岁或以上有实验室确诊的 SARS-CoV-2 感染的患者。将州免疫信息系统数据与病例联系起来,并使用定义的集水区人群的疫苗接种覆盖率数据比较未接种者和接种者的住院率。对具有详细病历回顾的代表性样本比较了接种者和未接种者的患者特征;计算了未加权病例数和加权百分比。

暴露

实验室确诊的 COVID-19 相关住院,定义为住院前 14 天或住院期间 SARS-CoV-2 检测结果阳性。

主要结果和措施

评估了接种者和未接种者的 COVID-19 相关住院率以及接种者中与 COVID-19 相关住院相关的因素。

结果

使用来自 192509 例住院患者的代表性数据(表 1 中为人口统计学信息),无论加强剂量状态如何,未接种者的每月 COVID-19 相关住院率是接种者的 3.5 至 17.7 倍。2022 年 1 月至 4 月,当 Omicron 变体占主导地位时,未接种者的住院率分别比接种者高 10.5 倍和未接种者高 2.5 倍,未接种者没有接受加强剂量。在抽样病例中,接种 COVID-19 的住院患者比未接种者年龄更大(中位数[IQR]年龄,70[58-80]岁比 58[46-70]岁,分别;P<0.001),并且更有可能有 3 种或更多基础疾病(分别为 1926[77.8%]和 4124[51.6%];P<0.001)。

结论和相关性

在这项针对美国 COVID-19 住院成年人的横断面研究中,与接种者相比,未接种者更有可能住院;接种加强剂量者的住院率最低。与未接种的住院患者相比,接种疫苗的住院患者年龄更大,并且更有可能有 3 种或更多基础疾病,并且是长期护理机构的居民。研究结果表明,临床医生和公共卫生工作者应继续为符合条件的人推广所有推荐剂量的疫苗接种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/9459904/2787cccb6bd1/jamainternmed-e224299-g001.jpg

相似文献

引用本文的文献

1
Long-Term Effects of COVID-19 on Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2025 Jul 18;20:2539-2548. doi: 10.2147/COPD.S523149. eCollection 2025.
2
Adolescents' knowledge of and confidence in vaccines improves with board game play.
Discov Educ. 2025;4(1):245. doi: 10.1007/s44217-025-00683-4. Epub 2025 Jul 19.
3
Vaccine Effects on In-hospital COVID-19 Outcomes.
Epidemiology. 2025 Sep 1;36(5):646-649. doi: 10.1097/EDE.0000000000001877. Epub 2025 Jun 17.
7
Health and Economic Impact of COVID-19 Surveillance Testing in Seattle Homeless Shelters: A Cost-Effectiveness Analysis.
AJPM Focus. 2024 Dec 5;4(2):100307. doi: 10.1016/j.focus.2024.100307. eCollection 2025 Apr.

本文引用的文献

5
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.
N Engl J Med. 2022 Apr 14;386(15):1397-1408. doi: 10.1056/NEJMoa2118542. Epub 2022 Feb 16.
6
Outpatient Remdesivir to Prevent Progression to Severe Covid-19. Reply.
N Engl J Med. 2022 Mar 17;386(11):1094. doi: 10.1056/NEJMc2200591. Epub 2022 Feb 16.
9
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
JAMA. 2021 Nov 23;326(20):2043-2054. doi: 10.1001/jama.2021.19499.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验